Gleam vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionGleamIsomorphic Labs
PricingContact for pricingContact for pricing
Target CustomerClinical research sites & coordinatorsLarge pharma & research institutions
Core TechnologyBrowser extension for automated EDC data entryAI predictive & generative models for drug design
Key IntegrationsBrowser-based sources & EDCs (no custom setup)Pharma partnerships (Novartis, Johnson & Johnson)
DeploymentBrowser extension, cloud-basedCustom collaborations, no public API

Gleam and Isomorphic Labs serve entirely different markets. Gleam is a practical, site-driven data entry automation tool for clinical research coordinators, reducing transcription errors and audit prep. Isomorphic Labs is a high-end AI drug discovery partner for large pharma, using AlphaFold-based models for molecule design. Choose Gleam if you're a clinical site seeking to speed up EDC workflows; choose Isomorphic Labs if you're a pharma company pursuing multi-billion-dollar drug development collaborations.

Gleam
Gleam

Gleam is a browser extension that automates data entry for clinical research sites, moving data from any source to any EDC with zero integrations.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
Popularity
2 views
7.4k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
Categories
🧾 Healthcare Revenue Cycle🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
Automated data entry from any source to EDC CRFs
Context-aware AI field mapping for study, visit, patient
Fetch source data with a few clicks
Fill CRF fields with high confidence
Flag low-confidence entries for manual review
Source traceability for each data field
Error detection as you work
Works across browser-based sources and EDCs
Zero integrations needed
No complex installation
Starts without sponsor approval
Paper/PDF source support (coming soon)
Audit-ready data trail
Chrome browser extension
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: Gleam vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Gleam

101 mentions across 8 sources · 13% positive — critical

Hacker News, YouTube, Product Hunt, App Store, Bluesky, Stack Overflow, GitHub, Lemmy

What users praise

  • Automates data entry from EHR to EDC without custom integrations.
  • Context-aware field mapping for study, visit, and patient context.
  • Low-confidence field flagging prompts manual review for accuracy.
  • Source traceability per data field for audit-ready trails.

What frustrates them

  • Aggressive paywall appears immediately after app launch.
  • Free trial auto-renews for a full year without clear cancellation.
  • Pricing hidden behind questionnaire; $70/year disclosed last.
  • Many App Store reviews call it a scam or cash grab.

Researched Jul 28, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Clinical Research Coordinator
    Pick: Gleam

    Gleam automates data entry into EDCs, reducing transcription errors and freeing time for patient care. It integrates with browser-based sources without sponsor approval.

  • Site Director
    Pick: Gleam

    Gleam offers sponsor-independent workflow automation, cutting data entry time and audit prep overhead, ideal for sites using multiple EDCs.

  • Pharma VP of Drug Discovery
    Pick: Isomorphic Labs

    Isomorphic Labs provides AI-first predictive and generative models for novel molecule design, with proven pharma collaborations and deep AlphaFold expertise.

  • Research Institution Seeking AI Drug Design Partner
    Pick: Isomorphic Labs

    Isomorphic Labs combines world-class AI (AlphaFold) with drug discovery experience, suitable for large-scale programs requiring rapid lead optimization.

Frequently Asked Questions

Gleam vs Isomorphic Labs: which should you choose?

Gleam and Isomorphic Labs serve entirely different markets. Gleam is a practical, site-driven data entry automation tool for clinical research coordinators, reducing transcription errors and audit prep. Isomorphic Labs is a high-end AI drug discovery partner for large pharma, using AlphaFold-based models for molecule design. Choose Gleam if you're a clinical site seeking to speed up EDC workflows; choose Isomorphic Labs if you're a pharma company pursuing multi-billion-dollar drug development collaborations.

Which tool is cheaper?

Both are contact-based pricing; Gleam likely costs less for individual sites, while Isomorphic Labs involves multi-million dollar partnerships.

Can I use Isomorphic Labs directly as a software tool?

No. Isomorphic Labs operates through pharma collaborations only, not as a product or API. It's a partner for drug discovery programs.

Does Gleam require integration with my EDC?

No. Gleam works as a browser extension with any browser-based EDC, without custom integrations or sponsor approval.

Can Gleam handle paper sources?

Paper/PDF support is on the waitlist, coming soon. Currently, it works best with electronic sources.

What is the latest news about Isomorphic Labs?

Most recent: Series B in February 2026 (announced May 2026), and a collaboration with Johnson & Johnson announced January 2026.

What is the latest news about Gleam?

Recent news unrelated to product: a DNS server in Gleam, and a report on AI human labor. No product updates announced.

Are these tools competitors?

No. Gleam is for clinical data entry at sites; Isomorphic Labs is for AI drug discovery at pharma. They serve completely different markets.

Which has stronger AI?

Isomorphic Labs uses Nobel Prize-winning AlphaFold for predictive protein-ligand models. Gleam uses context-aware AI for data entry, not comparable.

More Gleam or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026